• ABT-737: A Benchmark BCL-2 Protein Inhibitor for Apoptosis R

  2026-04-20

  ABT-737 stands apart as a selective BCL-2 protein inhibitor, enabling precise apoptosis induction in diverse cancer cell models. Discover how quantitative workflows, troubleshooting strategies, and insights from mitochondrial remodeling research can maximize both reproducibility and scientific impact.

• Reliable Native Electrophoresis with Basic Protein Native PA

  2026-04-19

  This article addresses key challenges in native protein gel electrophoresis for acidic proteins, guiding biomedical researchers toward robust, reproducible workflows with the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) (SKU K4142). Evidence-based scenarios demonstrate how K4142 supports activity-preserving analysis and protein purification in demanding cell biology and translational assays.

• BIIE 0246: Applied Workflows for Neuropeptide Y Y2 Receptor

  2026-04-18

  BIIE 0246 from APExBIO enables precise, reproducible NPY Y2 receptor inhibition in neurobehavioral and metabolic assays. This guide outlines optimized experimental workflows, troubleshooting strategies, and translational insights from the latest adipose-neural axis research.

• L. gasseri Modulates Colitis via NR1I3-Dependent E-cadherin

  2026-04-17

  Qian et al. (2024) demonstrate that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by restoring intestinal barrier integrity through NR1I3-mediated upregulation of E-cadherin. This mechanistic insight advances our understanding of probiotic action in IBD and highlights E-cadherin as a key therapeutic target.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor in Cancer Met

  2026-04-16

  7ACC2 stands out as a dual-action monocarboxylate transporter 1 inhibitor, uniquely disrupting both lactate and pyruvate flux to empower cancer metabolism research. Its nanomolar potency and robust translational data make it indispensable for dissecting tumor metabolic vulnerabilities and advancing immunometabolic checkpoint studies.

• Advancing Pharmacokinetic Studies with hiPSC-Derived Intesti

  2026-04-15

  This article examines the development and application of human pluripotent stem cell-derived intestinal organoids for pharmacokinetic studies, highlighting the streamlined 3D culture protocol introduced by Saito et al. The findings have significant implications for improving in vitro drug absorption and metabolism assays, particularly for compounds modulating β-adrenergic signaling.

• GPR30+ Spinal Neurons Drive Neuropathic Pain: Mechanisms and

  2026-04-14

  Chen et al. (2024) reveal that GPR30, a membrane estrogen receptor, is upregulated in spinal cholecystokinin-positive (CCK+) neurons following nerve injury and is essential for neuropathic pain hypersensitivity. Their mechanistic dissection using chemogenetics and GPR30 inhibition highlights a new cellular target and pathway for pain modulation, opening avenues for estrogen signaling research in pain.

• Solving Cell Assay Challenges with DAPT (GSI-IX) SKU A8200

  2026-04-13

  This article delivers scenario-driven guidance for researchers using DAPT (GSI-IX) (SKU A8200) in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed data and real-world workflow analysis, we show how this selective γ-secretase inhibitor enhances reproducibility and interpretability in Alzheimer's disease research, cancer models, and studies of Notch signaling. Practical Q&A blocks equip bench scientists with evidence-based, actionable insights.

• Puromycin dihydrochloride: Protocols for Selection and Analy

  2026-04-12

  Puromycin dihydrochloride is an aminonucleoside antibiotic optimized for rapid protein synthesis inhibition and stable cell line selection in molecular biology workflows. It is best applied when working with pac gene-expressing systems or for direct analysis of translation mechanisms. Avoid use where non-selective cytotoxicity may obscure results or where resistance mechanisms are poorly defined.

• Ziprasidone HCl in Oncology and Neuroscience: Applied Workfl

  2026-04-12

  Ziprasidone Hydrochloride bridges neuroscience and oncology research with dual-action as a serotonin/dopamine antagonist and GOT1 inhibitor. This guide delivers workflow-ready protocols, troubleshooting strategies, and evidence-driven benchmarks for applied cell and animal studies using APExBIO’s trusted Ziprasidone HCl.

• RSL3: GPX4 Inhibitor for Ferroptosis-Driven Cancer Research

  2026-04-11

  Leverage (1S,3R)-RSL3 as a precise glutathione peroxidase 4 inhibitor to interrogate ferroptosis and synthetic lethality in RAS-driven tumor models. This article details validated protocols, experimental pitfalls, and evidence-based troubleshooting to empower robust, reproducible studies in cancer biology.

• Vernakalant Hydrochloride: Applied Workflows for Rapid AF Co

  2026-04-11

  Vernakalant Hydrochloride (RSD1235) empowers researchers with precise, atrial-selective antiarrhythmic action for rapid conversion of atrial fibrillation. This article translates advanced pharmacology into actionable protocols and troubleshooting insights, enabling next-generation AF research with APExBIO’s trusted quality.

• Ferrostatin-1 (Fer-1): Reliable Ferroptosis Inhibition in...

  2026-04-10

  This article delivers a scenario-driven, evidence-based resource for optimizing ferroptosis research using Ferrostatin-1 (Fer-1), SKU A4371. Focusing on common laboratory challenges, it demonstrates how Fer-1 ensures reproducible, quantitative inhibition of iron-dependent oxidative cell death in cancer, neurodegeneration, and ischemic injury models. Biomedical researchers will find actionable guidance for protocol design, data interpretation, and vendor selection.

• Itraconazole: Triazole Antifungal Agent for Advanced Cand...

  2026-04-09

  Itraconazole, a potent triazole antifungal and CYP3A4 inhibitor, is revolutionizing research on Candida biofilm resistance and antifungal drug interactions. Leveraging APExBIO’s validated Itraconazole (SKU B2104), researchers can access enhanced protocols, robust troubleshooting strategies, and actionable insight into drug resistance mechanisms in fungal infection models.

• Erastin: A Precision Ferroptosis Inducer for Cancer Biolo...

  2026-04-08

  Erastin is a highly characterized small molecule ferroptosis inducer that selectively triggers iron-dependent, non-apoptotic cell death in RAS- or BRAF-mutant tumor cells. Its validated mechanism—disruption of system Xc⁻ and modulation of VDAC—makes it a valuable tool for cancer biology and oxidative stress research. As a gold-standard reagent, Erastin enables reproducible insights in ferroptosis pathway studies.

450 records 21/30 page Previous Next First page 上5页 2122232425 下5页 Last page